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Chronic transplant failure, which is associated with early
acute rejection, has become one of the major challenges in
the care of kidney transplant patients. Several novel tech-
niques have been used to identify biological markers for
acute transplant rejection as well as chronic allograft fail-
ure. These approaches include mRNA quantification from
allograft biopsies as well as from urine or blood samples
[1,2]. Although a number of studies have reported poten-
tial candidate biomarkers, to date none of these have been
introduced into routine diagnostics. In addition to the tech-
nical challenges in applying this information, it may also
be in part due to the complexity of the underlying biology
of gene regulation.
The human genome is more than a library of discrete
genes, and gene regulation goes beyond switching on or
off the transcription of protein-encoding messenger ribonu-
cleic acid (mRNA). A majority of genes can undergo alter-
native splicing yielding unique transcripts, which may also
be regulated by different promoters [3]. An additional level
of regulation at the level of microRNAs (miRNAs) has been
recently added to this scheme. miRNAs are single-stranded
RNAs of ∼22 nucleotides in length, which are not trans-
lated into a peptide but have regulatory properties. Since
their initial description in 1993, hundreds of miRNAs have
been identified [4]. miRNAs are transcribed as longer pri-
mary transcripts (pri-miRNA), which are cleaved by the nu-
clear enzyme Drosha to precursor miRNAs (pre-miRNAs)
(Figure 1). The pre-miRNA then exits the nucleus and is
further processed to a mature miRNA by the RNase Dicer.
After entering the RNA-induced silencing complex (RISC),
the specific miRNA binds to its target mRNA leading to
suppression of translation. The dimension of the potential
effects of this class of biological regulators becomes more
obvious when one considers that up to two-thirds of protein-
coding mRNAs may be regulated by miRNAs [5]. Our cur-
rent understanding of the multifaceted nature of miRNA
biology has been recently extensively reviewed elsewhere
[6]. Changes in specific miRNA levels have been reported
for various physiological processes as well as disease states
including kidney diseases as discussed below.
In a recent study, the group of Manikkam Suthanthiran,
who had already pioneered transcriptomic profiling in renal
transplantation [7], set out to characterize potential associ-
ations of intrarenal miRNA levels with the clinical and
histological status of renal allografts [8]. They conducted
a global miRNA expression study on four renal protocol
biopsies with a normal histology and three biopsies with
acute rejection (AR) and graft dysfunction. A subset of 17
miRNAs (out of an initial group of 365 miRNAs on the
analysis platform) were found showing differential expres-
sion in both cohorts. A subset of these miRNAs were then
quantified in an additional group of biopsies (17 protocol
biopsies and 9 AR). The altered expression of 6 of the 17
miRNAs was again observed in this confirmatory analysis.
The authors went on to study if miRNA levels could predict
AR and graft function. They reported impressive sensitivity
and specificity values for two to three miRNAs in this co-
hort and association of some of the miRNAs with estimated
glomerular filtration rate for these biopsies. To gain further
insight into the underlying biology, miRNA levels were
correlated with cell type-specific mRNA templates (e.g.
CD3 and CD20). In addition, miRNA levels were studied
in isolated peripheral blood mononuclear cells (PBMCs)
and human renal tubular epithelial cells. Some miRNAs
found to be increased in AR were also found to be ex-
pressed in PBMCs. This indicates that cell infiltration and
immunological processes may help explain the changes in
miRNA levels. Indeed, regulatory potentials in immune-
competent cells were previously reported for some of the
miRNAs. The report by Anglicheau et al. follows a sec-
ond paper on miRNA quantification on a smaller number
of allograft biopsies [9]. Both studies should help to fuel
further research on miRNA and allograft damage as well as
in native kidney disorders. The important questions that re-
main include which changes in miRNA expression are due
to AR alone, and which may be triggered by other factors
such as renal function, time since transplantation and other
parameters.
The study adds to the accumulating data on the gen-
eral importance of miRNAs for the proper function of the
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Fig. 1. miRNAmaturation and function. In humans, primarymiRNA (pri-
miRNA) is transcribed and is cleaved by Drosha. The resulting precursor
miRNA (pre-miRNA) exits the nucleus and is processed byDicer tomature
miRNA. It enters the RNA-induced silencing complex (RISC) and leads
to sequence-specific translational suppression of target mRNA. In this
scheme all steps of miRNAmaturation and function had to be substantially
simplified; for a more complete overview, relevant review articles are
recommended (e.g. [6]).
kidney. This was elegantly demonstrated by Tian et al., who
showed in rats differential levels of specific miRNAs in the
renal medulla as compared to the cortex together with re-
ciprocal expression of the predicted target genes [10]. In the
framework of renal disease, Pandey et al. performed an ex-
tensive profiling study again in rats and found that miRNAs
were involved in the development of polycystic kidney dis-
ease [11]. This finding is supported by work from Lee et al.
who showed that a specific miRNA (miR15a) regulates the
translation of the cell-cycle regulator Cdc25A in liver cysts.
Reduction of miR15a levels in cholangiocytes led to an in-
crease of the Cdc25A protein accompanied by acceleration
in cyst growth [12]. Some of the most convincing evidence
for a critical role of miRNAs in renal function comes from
studies of the glomerulus. Three recent publications all re-
ported that podocyte-specific deletion of Dicer, the central
RNAse for miRNAmaturation, leads to proteinuria accom-
panied by foot-process effacement and alterations of the
glomerular basement membrane in mice. All three models
showed a progressive decline of renal function with high
proteinuria and tubular injury with protein cast formation
[13–15]. These data elegantly demonstrate thatmiRNAs are
not only essential for intracellular regulation of target mR-
NAs but also that cell-specific interruption has detrimental
effects on the function of the entire biological unit, which in
the kidney is the nephron. This is further supported by two
additional reports demonstrating that alterations of specific
miRNAs in mesangial cells can lead to a pro-fibrotic milieu
in the glomerulus [16,17].
Our understanding of miRNA biology is still incomplete,
so the interpretation of all these studies is only preliminary.
With our current knowledge, it is very difficult to accu-
rately predict the target genes of a specific miRNA [18].
Therefore, the effects downstream of miRNA changes are
still vague. In addition, the effects of miRNAs may go be-
yond the inhibition of target mRNA translation and may
also include activation of translation [19].
miRNAs have proven to be of key relevance in the reg-
ulation of gene expression, and by this, for organ function.
Specific alterations in miRNA levels are clearly involved
in disease processes such as nephropathies. However, the
qualification of miRNA levels as biomarkers in nephrol-
ogy, including in renal transplants, remains elusive. Fu-
ture efforts should be combined to help identify reliable
biomarkers for diagnosis, outcome and response to ther-
apy in transplant nephrology as well as in primary renal
diseases.
Take home message
miRNAs are a central mechanism for gene regulation and
specific miRNAsmay prove to function as biological mark-
ers for acute allograft rejection.
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